Phage-encoded depolymerases as a strategy for combating multidrug-resistant Acinetobacter baumannii
Md Minarul Islam1,2, Nasir Uddin Mahbub3, Woo Shik Shin4
1Department of Microbiology, College of Science and Technology, Dankook University, Cheonan, Republic of Korea.
Abstract:
Acinetobacter baumannii, a predominant nosocomial pathogen, represents a grave threat to public health due to its multiple antimicrobial resistance. Managing patients afflicted with severe infections caused by multiple drug-resistant A. baumannii is particularly challenging, given the associated high mortality rates and unfavorable prognoses. The diminishing efficacy of antibiotics against this superbug underscores the urgent necessity for novel treatments or strategies to address this formidable issue. Bacteriophage-derived polysaccharide depolymerase enzymes present a potential approach to combating this pathogen. These enzymes target and degrade the bacterial cell's exopolysaccharide, capsular polysaccharide, and lipopolysaccharide, thereby disrupting biofilm formation and impairing the bacteria's defense mechanisms. Nonetheless, the narrow host range of phage depolymerases limits their therapeutic efficacy. Despite the benefits of these enzymes, phage-resistant strains have been identified, highlighting the complexity of phage-host interactions and the need for further investigation. While preliminary findings are encouraging, current investigations are limited, and clinical trials are imperative to advance this treatment approach for broader clinical applications. This review explores the potential of phage-derived depolymerase enzymes against A. baumannii infections.
Insights
Novel phage depolymerase enzymes show promise against multidrug-resistant Acinetobacter baumannii infections. These enzymes degrade bacterial defenses, but their narrow host range and emerging resistance require further research for clinical use.
Area of Science:
- Microbiology
- Biotechnology
- Infectious Diseases
Background:
- Acinetobacter baumannii is a major cause of hospital-acquired infections.
- Its multidrug resistance poses significant treatment challenges and high mortality rates.
- Existing antibiotics are becoming less effective against this superbug.
Purpose of the Study:
- To explore the potential of bacteriophage-derived polysaccharide depolymerase enzymes as a novel therapeutic strategy against Acinetobacter baumannii.
- To review the mechanisms of action and limitations of these enzymes.
Main Methods:
- Literature review of studies on phage depolymerases and Acinetobacter baumannii.
- Analysis of enzyme mechanisms targeting bacterial exopolysaccharides, capsular polysaccharides, and lipopolysaccharides.
- Evaluation of enzyme efficacy in disrupting biofilm formation and bacterial defense.
Main Results:
- Phage depolymerases can degrade key components of the Acinetobacter baumannii cell surface.
- Enzyme activity disrupts biofilm formation and enhances bacterial susceptibility.
- Limitations include a narrow host range and the emergence of phage-resistant strains.
Conclusions:
- Phage-derived depolymerase enzymes represent a promising avenue for combating multidrug-resistant Acinetobacter baumannii.
- Further research and clinical trials are necessary to overcome limitations and establish therapeutic efficacy.
- Developing strategies to broaden host range and manage resistance is crucial for clinical application.
Related Concept Videos
Lytic Cycle of Bacteriophages
Gene Regulation in Microbial Communities: Quorum Sensing
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Development of Antibiotic Resistance
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...


